NCT01137032

Study to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population

An Open -Label Study to Evaluate the Effect of Pandel Cream 0.1% on the Hypothalamic Pituitary Adrenal Axis in the Pediatric and Adult Population

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: Fougera Pharmaceuticals Inc. · Industry
• Sex: All
• Age: 3 Months
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the effect of Pandel® (hydrocortisone probutate cream) Cream 0.1% on the Hypothalamic Pituitary Adrenal (HPA) axis in pediatric and adult subjects with either psoriasis or atopic dermatitis involving greater than 20% body surface area.

Conditions

• Psoriasis
• Atopic Dermatitis

Interventions

Type	Name	Description
DRUG	Pandel Cream 0.1%	A thin coat of cream will be applied and rubbed into the affected areas, as well as normal skin, twice daily for 21 days

Timeline

• Start date: 2004-06-01
• Primary completion: 2005-08-01
• Completion: 2005-08-01
• First posted: 2010-06-04
• Last updated: 2016-05-04
• Results posted: 2016-03-29

Locations

3 sites across 1 country: United States